Literature DB >> 28110848

Cementless Hip Stem Anteversion in the Dysplastic Hip: A Comparison of Tapered Wedge vs Metaphyseal Filling.

Naofumi Taniguchi1, Tetsuya Jinno2, Daisuke Koga2, Tetsuo Hagino3, Atsushi Okawa2, Hirotaka Haro4.   

Abstract

BACKGROUND: Appropriate stem anteversion is important for achieving stability of the prosthetic joint in total hip arthroplasty. Anteversion of a cementless femoral stem is affected by the femoral canal morphology and varies according to stem geometry. We investigated the difference and variation of the increase in anteversion between 2 types of cementless stems, and the correlation between each stem and the preoperative femoral anteversion.
METHODS: We retrospectively compared 2 groups of hips that underwent total hip arthroplasty using a metaphyseal filling stem (78 hips) or a tapered wedge stem (83 hips). All the patients had osteoarthritis due to hip dysplasia. Computed tomography was used to measure preoperative femoral anteversion at 5 levels and postoperative stem anteversion.
RESULTS: The increase in anteversion of the tapered wedge stem group (22.7° ± 11.6°) was more than that of the metaphyseal filling stem group (17.2° ± 8.3°; P = .0007). The variation of the increase in the tapered wedge stem group was significantly larger than that in the metaphyseal filling stem group (P = .0016). The metaphyseal filling stem group was more highly and positively correlated with femoral anteversion than the tapered wedge stem group.
CONCLUSION: Femoral anteversion affects stem anteversion differently according to stem geometry. The tapered wedge stems had greater variation of the increase in anteversion than did the metaphyseal filling stems. Based on the results of this study, it is difficult to preoperatively estimate the increase in stem anteversion for tapered wedge stems.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Level III; cementless stem; dislocation; femoral canal; impingement; instability; stem geometry; therapeutic study

Mesh:

Substances:

Year:  2016        PMID: 28110848     DOI: 10.1016/j.arth.2016.12.020

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  6 in total

1.  Distribution and outliers of anteversion of short-length cementless stem.

Authors:  Hong-Seok Kim; Young-Kyun Lee; Joo-Hyung Ha; Se Jin Park; Jung-Wee Park; Kyung-Hoi Koo
Journal:  Int Orthop       Date:  2021-11-20       Impact factor: 3.075

2.  Mid-term results of short-stem total hip arthroplasty in patients with Crowe type I and II developmental dysplasia of the hip.

Authors:  Yingyong Suksathien; Thanut Tippimanchai; Tossaporn Akkrasaeng; Chakkrit Ruangboon
Journal:  Eur J Orthop Surg Traumatol       Date:  2020-09-01

3.  Preoperative Planning for Total Hip Arthroplasty for Neglected Developmental Dysplasia of the Hip.

Authors:  Xiao-Tong Shi; Chao-Feng Li; Cheng-Ming Cheng; Chun-Yang Feng; Shu-Xuan Li; Jian-Guo Liu
Journal:  Orthop Surg       Date:  2019-06-13       Impact factor: 2.071

4.  Effect of altered proximal femoral geometry on predicting femoral stem anteversion in patients with developmental dysplasia of the hip.

Authors:  Chenhui Huang; Haitao Tan; Willem Alexander Kernkamp; Rongshan Cheng; Junjie Liang; Zhenan Zhu; Seung-Hoon Baek; Liao Wang; Tsung-Yuan Tsai
Journal:  J Orthop Surg Res       Date:  2019-12-09       Impact factor: 2.359

5.  Peri-prosthetic bone remodeling of hydroxyapatite-coated compaction short stem was not affected by stem alignment.

Authors:  Shinya Hayashi; Yuichi Kuroda; Naoki Nakano; Tomoyuki Matsumoto; Tomoyuki Kamenaga; Toshihisa Maeda; Takahiro Niikura; Ryosuke Kuroda
Journal:  J Orthop Surg Res       Date:  2022-03-03       Impact factor: 2.359

6.  Survival rates and reasons for revision of different stem designs in total hip arthroplasty for developmental dysplasia: a regional registry study.

Authors:  Alberto Di Martino; Francesco Castagnini; Niccolò Stefanini; Barbara Bordini; Giuseppe Geraci; Federico Pilla; Francesco Traina; Cesare Faldini
Journal:  J Orthop Traumatol       Date:  2021-07-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.